Clinical features of spinal cord sarcoidosis: analysis of 17 neurosarcoidosis patients

被引:38
作者
Sakushima, Ken [1 ]
Yabe, Ichiro [1 ]
Nakano, Fumihito [2 ]
Yoshida, Kazuto [2 ]
Tajima, Yasutaka [3 ]
Houzen, Hideki [4 ]
Maruo, Yasunori [5 ]
Sasaki, Hidenao [1 ]
机构
[1] Hokkaido Univ, Grad Sch Med, Dept Neurol, Sapporo, Hokkaido, Japan
[2] Asahikawa Red Cross Hosp, Dept Neurol, Asahikawa, Hokkaido, Japan
[3] Sapporo City Gen Hosp, Dept Neurol, Sapporo, Hokkaido, Japan
[4] Obihiro Kosei Gen Hosp, Dept Neurol, Obihiro, Hokkaido, Japan
[5] Hakodate Municipal Hosp, Dept Neurol, Hakodate, Hokkaido, Japan
关键词
Neurosarcoidosis; Spinal cord sarcoidosis; Cerebrospinal fluid; Angiotensin-converting enzyme; MANAGEMENT; DIAGNOSIS;
D O I
10.1007/s00415-011-6080-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The diagnosis of neurosarcoidosis is often difficult; the imaging signs of spinal cord sarcoidosis sometimes mimic those of cervical spondylotic myelopathy, which is common in elderly persons. We examined the characteristics of spinal cord sarcoidosis in Japanese patients with neurosarcoidosis. This case series identified patients with neurosarcoidosis at four general hospitals and one university hospital from April 1998 to September 2010. All diagnoses were based on the diagnostic criteria proposed by Zajicek et al. Seventeen patients (nine men and eight women) were involved: six patients with spinal cord lesions accompanied by cervical spondylosis, five with cerebral lesions, three with cranial nerve lesions, two with meningitis, and one with nerve root lesions. Patients with spinal cord sarcoidosis had a higher onset age, longer duration from onset to diagnosis, reduced leukocytosis in the cerebrospinal fluid (CSF), and lower angiotensin-converting enzyme (ACE) levels in the CSF. The results of this study indicate that diagnosis of spinal cord sarcoidosis requires careful evaluation.
引用
收藏
页码:2163 / 2167
页数:5
相关论文
共 18 条
[11]   Clinical significance of intramedullary Gd-DTPA enhancement in cervical myelopathy [J].
Ozawa, H. ;
Sato, T. ;
Hyodo, H. ;
Ishii, Y. ;
Morozumi, N. ;
Koizumi, Y. ;
Matsumoto, F. ;
Kasama, F. ;
Aizawa, T. ;
Itoi, E. ;
Kokubun, S. .
SPINAL CORD, 2010, 48 (05) :415-422
[12]  
Rybicki BA, 1997, AM J EPIDEMIOL, V145, P234, DOI 10.1093/oxfordjournals.aje.a009096
[13]   FDG-PET SUV can distinguish between spinal sarcoidosis and myelopathy with canal stenosis [J].
Sakushima, Ken ;
Yabe, Ichiro ;
Shiga, Tohru ;
Yashima-Yamada, Moemi ;
Tsuji-Akimoto, Sachiko ;
Terae, Satoshi ;
Sasaki, Hidenao .
JOURNAL OF NEUROLOGY, 2011, 258 (02) :227-230
[14]  
Sakushima K, 2009, J CLIN NEUROSCI, V16, P1608, DOI 10.1016/j.jocn.2008.12.017
[15]  
Saleh S, 2006, J NATL MED ASSOC, V98, P965
[16]  
TAKAHASHI I, 2010, SHINKEI CHIRYOGAKU, V27, P209
[17]   Spinal cord sarcoidosis: report of seven cases [J].
Varron, L. ;
Broussolle, C. ;
Camdessanche, J. -P. ;
Marignier, R. ;
Rousset, H. ;
Ninet, J. ;
Seve, P. .
EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (03) :289-296
[18]   Central nervous system sarcoidosis - diagnosis and management [J].
Zajicek, JP ;
Scolding, NJ ;
Foster, O ;
Rovaris, M ;
Evanson, J ;
Moseley, IF ;
Scadding, JW ;
Thompson, EJ ;
Chamoun, V ;
Miller, DH ;
McDonald, WI ;
Mitchell, D .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 1999, 92 (02) :103-117